← Back to Search

Geriatric Assessment for Older Cancer Patients

N/A

Recruiting

Led By Lisa Marie Lowenstein, PhD, MPH

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Care Partner/Caregiver Participants: Fluent in English (reading and speaking)

Practice Staff Participants: Fluent in English (reading and speaking)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up monthly over 12 months of implementation, and 6 months after implementation

Awards & highlights

Study Summary

This trial is testing whether a program to improve communication between older cancer patients and their caregivers about age-related concerns can help improve patient outcomes.

Who is the study for?

This trial is for older adults with cancer who are considering or undergoing chemotherapy, and their caregivers. Participants must be over 18, fluent in English, and have access to a computer or smart device. Clinicians and practice staff can also join. Those planning to leave their practice within six months or unable to consent are excluded.Check my eligibility

What is being tested?

The study tests the effectiveness of Geriatric Assessment (GA) on improving communication about age-related concerns between patients/caregivers and healthcare providers, satisfaction with this communication, quality of life, and management of chemotherapy side effects.See study design

What are the potential side effects?

Since the intervention involves assessment rather than medication or medical procedures, there may not be direct physical side effects; however, participants might experience discomfort discussing personal health concerns during the assessment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My caregiver can read and speak English fluently.

Select...

I can read and speak English fluently.

Select...

I am 65 years old or older.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ monthly over 12 months of implementation, and 6 months after implementation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~monthly over 12 months of implementation, and 6 months after implementation

This trial's timeline: 3 weeks for screening, Varies for treatment, and monthly over 12 months of implementation, and 6 months after implementation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Reach of Geriatric Assessment (GA) implementation in routine medical practice

Reach of Geriatric Assessment (GA) implementation in routine medical practice as measured by applying the reach formula (# people served divided by potential # of people) to the following four metrics

Trial Design

1Treatment groups

Experimental Treatment

Group I: Geriatric Assessment (GA)Experimental Treatment1 Intervention

Clinical staff undergo training in GA and are provided with facilitation and support for one year as they implement GA among older adult patients (65+) considering chemotherapy and their care partners/caregivers.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,974 Previous Clinical Trials

1,787,976 Total Patients Enrolled

Patient-Centered Outcomes Research InstituteOTHER

551 Previous Clinical Trials

29,995,958 Total Patients Enrolled

9 Trials studying Communication

26,600 Patients Enrolled for Communication

Lisa Marie Lowenstein, PhD, MPHPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Geriatric Assessment Clinical Trial Eligibility Overview. Trial Name: NCT05436327 — N/A

Communication Research Study Groups: Geriatric Assessment (GA)

Communication Clinical Trial 2023: Geriatric Assessment Highlights & Side Effects. Trial Name: NCT05436327 — N/A

Geriatric Assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05436327 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are receiving treatments associated with this clinical investigation?

"Yes, the clinicaltrials.gov repository suggests that this trial is now in search of subjects. It was first made public on May 6th 2022 and recently modified on August 16th 2022; it seeks to recruit 1500 patients from a single hospital or clinic."

Answered by AI

Is this study seeking additional participants at the present?

"Clinicaltrials.gov indicates that this research trial is actively recruiting individuals for participation; it was initially broadcast on May 6th 2022 and the most recent update to its information took place on August 16, 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

2022. "Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05436327.